Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-06-14 @ 3:36 AM
Study NCT ID:
NCT04633902
Status:
UNKNOWN
Last Update Posted:
2022-12-06
First Post:
2020-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Sponsor:
California Pacific Medical Center Research Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Melanoma | View |